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Knowledge about the normal human cerebrospinal ﬂuid (CSF)
proteome serves as a baseline reference for CSF biomarker
discovery and provides insight into CSF physiology. In this study,
high-pH reverse-phase liquid chromatography (hp-RPLC) was ﬁrst
integrated with a TripleTOF 5600 mass spectrometer to compre-
hensively proﬁle the normal CSF proteome. A total of 49,836
unique peptides and 3256 non-redundant proteins were identi-
ﬁed. To obtain high-conﬁdence results, 2513 proteins with at least
2 unique peptides were further selected as bona ﬁde CSF proteins.
Nearly 30% of the identiﬁed CSF proteins have not been previously
reported in the normal CSF proteome. More than 25% of the CSF
proteins were components of CNS cell microenvironments, andvier Inc. This is an open access article under the CC BY license
/j.jprot.2015.01.017
inical Medical Research, Beijing Tiantan Hospital, Capital Medical University,
Zhang), gzg0625@sina.com (Z. Guo), tiantanwyj@aliyun.com (Y. Wang),
rk.
Y. Zhang et al. / Data in Brief 3 (2015) 103–107104network analyses indicated their roles in the pathogenesis of
neurological diseases. The top canonical pathway in which the CSF
proteins participated was axon guidance signaling. More than
one-third of the CSF proteins (788 proteins) were related to
neurological diseases, and these proteins constitute potential CSF
biomarker candidates. The mapping results can be freely down-
loaded at http://122.70.220.102:8088/csf/, which can be used to
navigate the CSF proteome. For more information about the data,
please refer to the related original article [1], which has been
recently accepted by Journal of Proteomics.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Subject area BiologyMore speciﬁc
subject areaProteomicsType of data Tables
How data was
acquiredInstruments including Waters Acquity nano-UPLC system, AB SCIEX Triple TOF 5600 systemData format Analyzed
Experimental factors Protein samples were reduced with 10 mM DTT, alkylated with 55 mM iodoacetamide, digested using
sequencing-grade modiﬁed trypsin.
Experimental
featuresCSF pooled from 14 individuals (7 women and 7 men) was subjected to the depletion of 14 high-
abundance proteins with an immunoafﬁnity column. The ﬂow-through proteins, bound proteins, and
original proteins were collected separately, digested, and then separated into 30 fractions each by high-
pH RPLC. Total 90 fractions were subjected to nano-RPLC-MS/MS analysis.Data source location Beijing, China
Data accessibility The data in the data in brief, in the related original article [1] and at http://122.70.220.102:8088/csf/ can
be freely downloaded.Value of the data This study identiﬁed the largest high-conﬁdence dataset of the human CSF proteome. Some CSF proteins' abundances are quantiﬁed by the iBAQ method.
 High proportion of the CSF proteins is microenvironment components of CNS cells.
 High proportion of the CSF proteins participate in neurocyte connectivity.
 A large part of CSF proteins are biomarker candidates of neurological diseases.1. Data, experimental design, materials and methods
1.1. Data
Table 1 lists all the CSF proteins with at least 2 unique peptide identiﬁcations. Table 2 lists the
proteins and their abundances, which were quantiﬁed by the iBAQ [2] method. Table 3 lists the CSF
proteins that participate in the axon guidance signaling pathway. Table 4 lists the CSF proteins
involved in neurological diseases.
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CSF pooled from 14 patients (7 women and 7 men) who received spinal anesthesia before non-
neurological operations was subjected to a global proteomic analysis. The pooled sample was ﬁrst
depleted of 14 high-abundance proteins with an immunoafﬁnity column. The ﬂow-through proteins,
bound proteins, and original proteins (extracted from the CSF samples that were not subjected to
immunoafﬁnity depletion) were collected separately, digested according to the ﬁlter-aided sample
preparation method [3], and then separated into 30 fractions each by high-pH RPLC. Each fraction was
then subjected to proteomic analysis by nano-RPLC-MS/MS. In total, 90 LC-MS/MS runs were
performed on the 90 fractions from the pooled CSF samples, and the resulting data were used to
produce a comprehensive map of the human CSF proteome.
1.3. Materials and methods
1.3.1. Apparatuses
A TripleTOF 5600 mass spectrometer from AB Sciex (Framingham, MA, USA) and an ACQUITY UPLC
system from Waters (Milford, MA, USA) were used.
1.3.2. Reagents
Deionized water from a MilliQ RG ultrapure water system (Millipore, Bedford, MA, USA) was used
at all times. HPLC-grade acetonitrile and formic acid, ammonium bicarbonate, iodoacetamide,
dithiothreitol, sequencing-grade modiﬁed trypsin, and protease-inhibitor PMSF (phenylmethanesul-
fonyl ﬂuoride) were purchased from Sigma-Aldrich (St. Louis, MO, USA).
1.3.3. CSF collection
CSF samples were collected by lumbar puncture from patients who received spinal anesthesia
before non-neurological operations at Beijing Tiantan Hospital. These patients were checked by an
independent medical doctor to rule out neurological diseases and recent medication use. Following
collection, a subsample of each CSF sample was sent to a clinical laboratory for routine CSF
diagnostics. The remaining sample was immediately centrifuged for 10 min at 2500 g to remove
cellular components and subsequently aliquoted and stored at 80 1C for further analysis. A total of
14 samples from 14 individuals (7 women and 7 men, aged 24–55 years, with a median age of 28
years) were selected and subjected to quantitation by the Bradford method [4]. Equal protein amounts
from 14 CSF samples were mixed, resulting in the pooled CSF sample for the proteomic analyses. All
selected samples had normal clinical laboratory values with respect to microbiology, chemistry, and
cell counts. Approval for this study was obtained from our institutional review boards in accordance
with ethical regulations.
1.3.4. Immunoafﬁnity depletion of 14 high-abundance proteins
The pooled CSF sample, which contained approximately 1 mg of CSF protein, was depleted of 14
high-abundance proteins (albumin, IgG, α1-antitrypsin, IgA, IgM, transferrin, haptoglobin, α1-acid
glycoprotein, α2-macroglobulin, apolipoprotein A-I, apolipoprotein A-II, ﬁbrinogen, complement C3,
and transthyretin) using a 4.650 mm Human 14 afﬁnity LC column (Agilent, St. Louis, MO, USA)
with a Waters HPLC system (Milford, MA, USA). The separations were performed according to the
manufacturer's instructions regarding column usage and loading capacity. The ﬂow-through protein
sample and bound protein sample were collected separately. The two samples and the non-depleted
CSF sample (containing the original proteins) were subjected to the sample handling and analysis
procedures described below.
1.3.5. Protein digestion
A ﬁlter-aided sample preparation method [3] was used to digest the proteins in the three samples
(each contained 100 mg of CSF protein). Brieﬂy, the proteins were reduced with 20 mM DTT at 95 1C
for 3–5 min and washed once with 8 M urea on a 10 kDa ﬁlter at 14,000 g for 40 min. The samples
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urea. Next, the proteins were washed with 50 mM ammonium bicarbonate once and digested with
trypsin (1 μg/50 μg protein) overnight at 37 1C. After digestion, the three peptide mixtures derived
from the ﬂow-through, the bound sample and the non-depleted CSF sample were desalted on a
Waters Oasis C18 solid-phase extraction column and lyophilized for HPLC separation.
1.3.6. High-pH HPLC separation
The three lyophilized peptide mixtures were fractionated with a high-pH RPLC column from
Waters (4.6 mm250 mm, C18, 3 μm). Each peptide mixture was loaded onto the column in buffer A2
(H2O, pH¼10). The elution gradient was 5–30% buffer B2 (90% ACN, pH¼10; ﬂow rate, 1 mL/min) for
60 min. The eluted peptides were collected as one fraction per minute, and the 60 fractions collected
were re-suspended in 0.1% formic acid and pooled into 30 fractions. A total of 90 fractions produced
from the three peptide mixtures were analyzed by LC-MS/MS.
1.3.7. LC-MS/MS
Each fraction was analyzed with a reverse-phase C18 self-packed capillary LC column
(75 μm100 mm, 3 μm). The elution gradient was 5–30% buffer B1 (0.1% formic acid, 99.9% ACN;
ﬂow rate, 0.3 μL/min) for 40 min. A TripleTOF 5600 mass spectrometer was used to analyze the
fractions. The MS data were acquired using the high-sensitivity mode with the following parameters:
30 data-dependent MS/MS scans per full scan, full scans acquired at a resolution of 40,000 and MS/MS
scans at a resolution of 20,000, rolling collision energy, charge state screening (including precursors
with charge states of þ2–þ4), dynamic exclusion (exclusion duration 15 s), MS/MS scan range of
100–1800 m/z, and a scan time of 100 ms.
1.3.8. Database search
The MS/MS spectra were searched against the Swiss-Prot human database from the UniProt
website (www.uniprot.org) using Mascot software, version 2.3.02 (Matrix Science, UK). Trypsin
cleavage speciﬁcity was set with a maximum number of allowed missed cleavages of two.
Carbamidomethylation (C) was set as a ﬁxed modiﬁcation. The searches were performed using a
peptide and product ion tolerance of 0.05 Da. The resulting dataset was further ﬁltered using the
decoy database method in Scaffold (v 4.3.2).
1.3.9. Intensity-based absolute quantiﬁcation (iBAQ) of proteins
Protein abundances were estimated using the iBAQ algorithm [2]. The detailed protocol is provided
below:(1) The protein intensities were ﬁrst computed by Progenesis LC-MS (v2.6, Nonlinear Dynamics, UK)
as the sum of all identiﬁed peptide intensities (maximum peak intensities of the peptide elution
proﬁle, including all peaks in the isotope cluster).(2) The protein intensities were then divided by the number of theoretically observable peptides
(calculated by in-silico protein digestion; all fully tryptic peptides between 6 and 30 amino acids
were counted).(3) The resulting intensities were iBAQ values, which are shown as “Absolute iBAQ intensities” in
column K of Supplementary Table 2.(4) The relative iBAQ intensities (in column L of Supplementary Table 2) were computed by dividing
the absolute iBAQ intensities by the sum of all absolute iBAQ intensities.(5) The relative iBAQ intensities were applied to estimate the relative protein abundances (the
proportions of protein amounts to total CSF protein amount).(6) The protein abundances (or concentrations) in CSF were ﬁnally calculated by multiplying the
relative iBAQ intensities by 0.3 (the protein concentration of the pooled CSF sample).
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All identiﬁed CSF proteins were subjected to network and functional analyses using ingenuity
pathway analysis (IPA) version 9.0 (http://www.ingenuity.com) and the PANTHER classiﬁcation
system (http://www.pantherdb.org/genes/batchIdSearch.jsp) [5].Acknowledgments
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